Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Journal of Cardiac Failure
|
September 4, 2012
Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2
Richard Sheppard, Paul J Mather, Jeffrey D Alexis, et al.
Clinical Cardiology
|
June 7, 2007
Initial heart rate and systolic blood pressure predict outcomes in chronic heart failure patients who are evaluated for cardiac transplant
Juan M Aranda, Stephen E McIntyre, Charles T Klodell, et al.
American Heart Journal
|
October 11, 2011
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)
Daniel F Pauly, B Delia Johnson, R David Anderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 7, 2002
Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors
Thomas J Fraites, Mary R Schleissing, R Andrew Shanely, et al.
Pharmacogenetics and Genomics
|
May 3, 2005
Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy
Steven G Terra, Karen K Hamilton, Daniel F Pauly, et al.
Circulation
|
June 18, 2003
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease
Qi Chen, Steven E Reis, Candace Kammerer, et al.
Journal of Cardiac Failure
|
June 3, 2008
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
Roger J Hajjar, Krisztina Zsebo, Lawrence Deckelbaum, et al.
Pharmacogenetics and Genomics
|
May 15, 2007
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure
Maximilian T Lobmeyer, Yan Gong, Steven G Terra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 18, 2008
Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection
Mandeep R Mehra, Jon A Kobashigawa, Mario C Deng, et al.
Clinical Cardiology
|
May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
Christopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Journal of Cardiac Failure
|
September 4, 2012
Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2
Richard Sheppard, Paul J Mather, Jeffrey D Alexis, et al.
Clinical Cardiology
|
June 7, 2007
Initial heart rate and systolic blood pressure predict outcomes in chronic heart failure patients who are evaluated for cardiac transplant
Juan M Aranda, Stephen E McIntyre, Charles T Klodell, et al.
American Heart Journal
|
October 11, 2011
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)
Daniel F Pauly, B Delia Johnson, R David Anderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 7, 2002
Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors
Thomas J Fraites, Mary R Schleissing, R Andrew Shanely, et al.
Pharmacogenetics and Genomics
|
May 3, 2005
Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy
Steven G Terra, Karen K Hamilton, Daniel F Pauly, et al.
Circulation
|
June 18, 2003
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease
Qi Chen, Steven E Reis, Candace Kammerer, et al.
Journal of Cardiac Failure
|
June 3, 2008
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
Roger J Hajjar, Krisztina Zsebo, Lawrence Deckelbaum, et al.
Pharmacogenetics and Genomics
|
May 15, 2007
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure
Maximilian T Lobmeyer, Yan Gong, Steven G Terra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 18, 2008
Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection
Mandeep R Mehra, Jon A Kobashigawa, Mario C Deng, et al.
Clinical Cardiology
|
May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
Christopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
Page
of 9